Beijing Aosaikang Pharmaceutical Co., Ltd.

SZSE:002755.SZ

8.79 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 468.374448.492323.712407.9373.291338.558366.382495.669474.991535.53662.425770.192742.587931.4631,068.8931,211.529793.031709.235982.9231,234.5651,187.6081,113.5363,600.131105.997163.67262.081122.40389.276122.09632.15971.52542.43631.56732.8369.32727.50693.35987.964178.84581.974116.20793.843748.47622.848622.848548.5563.78
Cost of Revenue 95.27681.87172.01166.74272.24266.05670.28464.36246.44662.51381.43165.88765.96163.77565.17196.66482.05467.55380.85989.6487.3878.33228.01880.298128.47640.9890.32255.94998.22823.86951.57427.08834.72630.67945.4911.17566.34863.421119.64866.82288.41869.037041.14141.141146.5780
Gross Profit 373.098366.621251.701341.158301.048272.501296.098431.307428.545473.017580.994704.305676.626867.6881,003.7221,114.865710.977641.683902.0641,144.9251,100.2281,035.2033,572.11325.69935.19621.132.08133.32823.8688.2919.95115.348-3.1592.15123.83716.33227.01124.54459.19715.15227.78924.806748.47581.707581.707401.922563.78
Gross Profit Ratio 0.7970.8170.7780.8360.8060.8050.8080.870.9020.8830.8770.9140.9110.9320.9390.920.8970.9050.9180.9270.9260.930.9920.2420.2150.340.2620.3730.1950.2580.2790.362-0.10.0660.3440.5940.2890.2790.3310.1850.2390.26410.9340.9340.7331
Reseach & Development Expenses 55.90363.51257.458125.627166.576122.348199.155180.009117.90791.76779.28269.27495.91179.97987.67268.63251.75147.836110.30876.76460.56662.466278.3054.259054.829233.1890.75500000000000000029.45529.45599.640
General & Administrative Expenses -0.21725.172-34.83163.2230.50926.693-54.57978.253-4.97127.462-53.78383.498-10.61733.754-59.76138.277-16.12140.978-138.02164.42431.25657.09913.42417.303-4.04311.719-29.9318.293-7.43511.038-20.19910.479-4.9747.329-26.17814.562-2.9045.886-21.72811.37410.7666.534083.0883.08278.0230
Selling & Marketing Expenses 263.009256.958180.376236.153208.714214.98227.865327.087298.38340.388525.645453.671459.18559.59643.919720.045486.287430.651622.897749.045732.431686.9362,423.0951.4372.4072.0423.8551.8311.6851.5042.4832.0181.30.9662.4791.21.6920.8481.6732.3242.0160.7210391.062391.0621,289.7680
SG&A 294.243282.13145.545299.376209.223241.672173.286405.34293.409367.85471.862537.169448.563593.343584.158758.321470.165471.628484.876813.469763.687744.0352,436.51918.739-1.63613.761-26.07520.124-5.75112.542-17.71512.497-3.6748.296-23.69915.761-1.2126.734-20.05513.69812.7827.2550474.142474.1421,567.7910
Other Expenses -0.3280.99618.848-0.2680.252-10.884.926-49.59141.0156.34-1.0842.663-0.5362.5178.85612.7314.5934.717-8.883.2212.2629.33310.409-0.0110.06-0.0030.1010.2430.0660.011-3.2533.1260.0540.113-1.263-0.0010.1330.0070.330.0110.053-0.01400000
Operating Expenses 350.473349.764265.882386.848418.642353.22457.367535.758452.332465.957625.861568.442596.844682.785771.204843.268580.688525.971709.542904.338885.719822.392,868.15223.14523.56114.15720.31120.34214.76312.6517.64612.5511.0578.89616.43816.08916.0779.16718.66516.04716.7588.375626.97484.461484.461335.853478.99
Operating Income 22.62427.804-5.115-34.564-108.737-71.462-169.49-104.45-23.7879.734-26.634142.40389.438197.303245.521281.679142.459120.642207.862236.16215.486212.489729.0443.5154.7487.1739.527.4996.882-3.9781.63132.103-5.3951.4160.6545.22315.47527.183-0.7951.67616.574111.8897.89297.89267.87483.13
Operating Income Ratio 0.0480.062-0.016-0.085-0.291-0.211-0.463-0.211-0.050.018-0.040.1850.120.2120.230.2320.180.170.2110.1910.1810.1910.2030.0330.0290.1160.0780.0840.056-0.1240.0230.0710.067-0.1640.020.0240.0560.1760.152-0.010.0140.1770.1490.1570.1570.1240.147
Total Other Income Expenses Net 19.8570.99618.848-0.2680.2520.116-0.46610.9736.6068.376-1.0849.2049.12114.91621.85822.81316.7639.6476.46-1.20713.249.00935.4910.95-6.8280.227-2.132-5.26-2.1570.393-0.5923.2746.3741.449-6.1950.41-5.2570.106-13.0490.112-9.330.1289.62-2.231-2.231-8.3751.66
Income Before Tax 42.48128.813.733-34.832-108.485-71.346-169.957-93.478-17.18118.11-27.718145.06788.902199.82254.377294.411147.052125.359198.982239.379227.749221.823739.4533.5044.8077.179.6387.7256.948-3.9671.7136.0712.157-5.2961.2040.6535.67715.48327.483-0.7841.716.559121.595.66195.66159.49984.79
Income Before Tax Ratio 0.0910.0640.042-0.085-0.291-0.211-0.464-0.189-0.0360.034-0.0420.1880.120.2150.2380.2430.1850.1770.2020.1940.1920.1990.2050.0330.0290.1150.0790.0870.057-0.1230.0240.1430.068-0.1610.0170.0240.0610.1760.154-0.010.0150.1760.1620.1540.1540.1080.15
Income Tax Expense 4.6032.3691.2494.277-3.0134.0370.3891.765-0.8182.366-22.08318.8835.60423.1026.86444.15125.62319.1924.43335.58833.85534.15583.4090.9970.6350.9891.2221.233-1.5950.382-2.1041.1447.3191.351.630.212-0.2062.5175.184-0.8260.5412.55517.3114.47914.4799.07213.67
Net Income 44.0531.54536.126-26.203-89.861-75.383-170.346-95.243-16.36219.363-12.107128.84584.916178.254242.349251.215121.546106.516194.787204.024194.124188.023660.2322.2133.044.5883.9634.6516.321-3.9673.8174.9261.157-5.296-0.4260.4415.88312.96622.2980.0421.15914.005104.2181.18281.18250.42671.12
Net Income Ratio 0.0940.070.112-0.064-0.241-0.223-0.465-0.192-0.0340.036-0.0180.1670.1140.1910.2270.2070.1530.150.1980.1650.1630.1690.1830.0210.0190.0740.0320.0520.052-0.1230.0530.1160.037-0.161-0.0060.0160.0630.1470.1250.0010.010.1490.1390.130.130.0920.126
EPS 0.0480.030.04-0.028-0.097-0.081-0.18-0.1-0.0180.021-0.0130.140.0910.190.260.270.130.110.210.220.210.22.980.210.020.210.0250.030.038-0.0240.0230.0290.006-0.029-0.0250.0260.0560.112.480.0050.130.110.470.390.390.240
EPS Diluted 0.0480.030.04-0.028-0.097-0.081-0.18-0.098-0.0170.02-0.0130.140.0910.190.260.270.130.110.210.220.210.22.980.210.020.210.0250.030.038-0.0240.0230.0290.006-0.029-0.0250.0260.0560.112.480.0050.130.110.470.390.390.240
EBITDA 45.60124.7678.32-37.339-112.071-70.673-147.999-95.897-16.49814.735-37.308149.62190.709199.633253.403293.172144.845125.838195.347248.693242.216215.129731.3612.02719.0717.0514.70618.8599.104-4.365.1873.069-3.31-6.77213.9560.2435.78315.37754.246-0.89611.0316.432113.7599.76299.76270.13684.93
EBITDA Ratio 0.0970.0550.026-0.092-0.3-0.209-0.404-0.193-0.0350.028-0.0560.1940.1220.2140.2370.2420.1830.1770.1990.2010.2040.1930.2030.0190.1170.1140.120.2110.075-0.1360.0730.072-0.105-0.2060.2010.0090.0620.1750.303-0.0110.0950.1750.1520.160.160.1280.151